Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 14 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AFAMELANOTIDE | 1件: Afamelanotide Afamelanotide | 1件: Afamelanotide
Afamelanotide
💬1. AFAMELANOTIDE
| 1件: MC1R MC1R 💬1. AFAMELANOTIDE
| 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 2件: 159 159, 254 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Afamelanotide (16 mg implant) | 1件: Afamelanotide Afamelanotide | 1件: Afamelanotide
Afamelanotide
💬2. Afamelanotide (16 mg implant)
| 1件: MC1R MC1R 💬2. Afamelanotide (16 mg implant)
| 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 159 159 💬2. Afamelanotide (16 mg implant)
| |||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Ipilimumab | 1件: Ipilimumab Ipilimumab | 1件: Ipilimumab
Ipilimumab
💬3. Ipilimumab
| 1件: CTLA4 CTLA4 💬3. Ipilimumab
| 4件: Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬 4件: Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signa ... | 1件: 159 159 💬3. Ipilimumab
| |||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Isotretinoin | 1件: Isotretinoin Isotretinoin | 1件: Isotretinoin
Isotretinoin
💬4. Isotretinoin
| 2件: RARA RARA,RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, ... | 4件: 36 36, 39, 159, 160 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Liposomal T4N5 lotion | - | - | - | - | 1件: 159 159 💬5. Liposomal T4N5 lotion
| |||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬6. Nivolumab
| 1件: PDCD1 PDCD1 💬6. Nivolumab
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor ... | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬6. Nivolumab
| |||||||||||||||||||||||||||||||||||||||||||||||
| 7 | SCENESSE | 1件: Afamelanotide Afamelanotide | 1件: Afamelanotide
Afamelanotide
💬7. SCENESSE
| 1件: MC1R MC1R 💬7. SCENESSE
| 2件: Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 3件: 159 159, 161, 254 💬
| |||||||||||||||||||||||||||||||||||||||||||||||
| 8 | TRABECTEDINA | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬8. TRABECTEDINA
| - | - | 1件: 159 159 💬8. TRABECTEDINA
| |||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Trabectedine | - | - | - | - | 1件: 159 159 💬9. Trabectedine
| |||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Yondelis | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬10. Yondelis
| - | - | 1件: 159 159 💬10. Yondelis
|